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Protein ubiquitination regulates numerous cellular functions
in eukaryotes. The prevailing view about the role of RING or
U-box ubiquitin ligases (E3) is to provide precise positioning
between the attached substrate and the ubiquitin-conjugating
enzyme (E2). However, the mechanism of ubiquitin transfer
remains obscure. Using the carboxyl terminus of Hsc70-inter-
acting protein as a model E3, we show herein that although
U-boxbinding is required, it is not sufficient to trigger the trans-
fer of ubiquitin onto target substrates. Furthermore, additional
regions of theE3protein that have nodirect contactwithE2play
critical roles inmediating ubiquitin transfer fromE2 to attached
substrates. By combining computational structure modeling
and protein engineering approaches, we uncovered a conforma-
tional flexibility of E3 that is required for substrate ubiquitina-
tion. Using an engineered version of the carboxyl terminus of
Hsc70-interacting protein ubiquitin ligase as a research tool, we
demonstrate a striking flexibility of ubiquitin conjugation that
does not affect substrate specificity. Our results not only reveal
conformational changes of E3 during ubiquitin transfer but also
provide a promising approach to custom-made E3 for targeted
proteolysis.
Proteinmodification by ubiquitin andubiquitin-like proteins
is a common mechanism through which numerous cellular
pathways are regulated (1). The canonical cascade of ubiquiti-
nation involves the action of three enzymes, termed E1, E2, and
E3,which activate and then conjugate ubiquitin to its substrates
(2, 3). The E3 ligase catalyzes the final step in ubiquitin transfer
in a substrate-specific manner. Despite advances in under-
standing the enzymatic cascade of ubiquitination, the mecha-
nismof ubiquitin transfer to the substrate remains an outstand-
ing issue (4). In particular, the role of E3 ubiquitin ligases and
how they adapt to progressively modified substrates to main-
tain specific ubiquitin chain topology is still a mystery.
The known E3s belong to three protein families: HECT,
RING, and U-box. HECT domain enzymes form a covalent
intermediate with ubiquitin before the final transfer of ubiq-
uitin to substrates. In contrast, RING and U-box E3s have been
suggested to function as adaptors that position the substrate in
close proximity to the E2-ubiquitin thioester (E2-Ub) (5). It has
become common “wisdom” that the substrate has to be pre-
cisely positioned to get ubiquitinated (6). The positioning
hypothesis originally predicted that E3 substrates would have a
specific ubiquitination site. However, the absence of “consen-
sus” ubiquitination sites has become apparent in an increasing
list of E3 substrates (7–9). In addition, the crystal structures of
several ubiquitination machinery components have revealed a
puzzling gap (50 Å) between the substrate binding sites and
the E2 active sites (10, 11). This raises a fundamental question
in ubiquitin transfer. How does the ubiquitin molecule shuttle
from the E2 to substrates? Though several interesting models
for ubiquitin transfer have been proposed, only limited explicit
experimental evidence support these models (4).
We used carboxyl terminus of Hsc70-interacting protein
(CHIP)3 as amodel E3 system to investigate the role of substrate
positioning in its ubiquitination. CHIP is a protein quality con-
trol E3 that consists of an NH2-terminal tetratricopeptide
repeat (TPR) domain, a helical linker domain, and a COOH-
terminal U-box domain (12, 13). The TPR domain of CHIP
binds directly to EEVDmotifs located at the COOH termini of
Hsc/Hsp70 and Hsp90, whereas the U-box domains possess
ubiquitin ligase activity. CHIP recruits E2 enzymes of the
Ubc4/5 family to ubiquitinate misfolded proteins that occupy
the chaperone substrate-binding sites, thus remodeling the
chaperones from protein-refolding complexes to complexes
that promote degradation (14). Using the chaperone as an
adaptor, CHIP targets a variety of substrates for ubiquitination
(15). In the absence of substrates, CHIP is also able to ubiquiti-
nate the bound chaperones (16). Thus, there is apparent sub-
strate diversity forCHIP-mediated ubiquitination. Insights into
the mechanism of action of CHIP have been provided by an
x-ray crystal structurewhich reveals a remarkable, highly asym-
metric dimer (25). Here, we demonstrate the existence of
intrinsic structural flexibility in the CHIP homodimer that is
* This work was supported, in whole or in part, by National Institutes of Health
Grants GM61728, HL65619, and AG024282 (to C. P.) and GM75156 (to
W. J. C.).
□S The on-line version of this article (available at http://www.jbc.org) contains
supplemental references, Figs. S1–S4, and Movie S1.
1 To whom correspondence may be addressed: 301 Biotech Bldg., Division of
Nutritional Sciences, Cornell University, Ithaca, NY 14853. E-mail: sq38@
cornell.edu.
2 To whom correspondence may be addressed: 6022 Burnett-Womack Bldg.,
Division of Cardiology, University of North Carolina, Chapel Hill, NC 27599.
E-mail: cpatters@med.unc.edu.
3 The abbreviations used are: CHIP, carboxyl terminus of Hsc70-interacting
protein; TPR, tetratricopeptide repeat; Ub, ubiquitin; E2-Ub, ubiquitin-con-
jugated E2; GFP, green fluorescent protein; DTT, dithiothreitol; FKBP,
FK506 binding protein; FRB, FKBP12-rapamycin binding domain; TEV,
tobacco etch virus.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 284, NO. 39, pp. 26797–26802, September 25, 2009
© 2009 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
SEPTEMBER 25, 2009 • VOLUME 284 • NUMBER 39 JOURNAL OF BIOLOGICAL CHEMISTRY 26797
required for substrate polyubiquitination. The flexible ori-
entation allows CHIP to accommodate substrates with dif-
ferent sizes and structures. Mutations that restrict the flex-
ibility of CHIP markedly decrease substrate ubiquitination,
whereas maintaining flexibility enables us to rebuild a func-
tional ubiquitin ligase with altered substrate specificity. Our
results provide evidence for the importance of structural
flexibility in E3 ligases, which we propose is of general
importance to orchestrate progressive ubiquitin conjugation
on substrates.
EXPERIMENTAL PROCEDURES
Plasmids—Prokaryotic constructs expressing glutathione S-
transferase or His6-tagged CHIP, CHIP(K30A), CHIP(H260Q),
CHIP(TPR), UbcH5a, UbcH5a(C85A) were described previ-
ously. FK506 binding protein (FKBP) and FKBP12-rapamycin
binding domain (FRB) domains were amplified by PCR from
constructs pC4EN-F1 and pC4-RHE, respectively (provided by
ARIADPharmaceuticals, Inc). Green fluorescent protein (GFP)
andU-box fusion constructs weremade using standard cloning
techniques and were subcloned into pET vector (Novagen).
Antibodies andReagents—Monoclonal anti-Hsp70 (SPA810)
and Hsp70 purified protein were purchased from Stressgen.
Polyclonal anti-UbcH5 antibody was from Boston Biochem.
Monoclonal anti-FLAG was from Sigma, anti-hemagglutinin
from Roche Applied Science, anti-His6 from BD Biosciences.
Rabbit E1 and Ub(K0) were purchased from Boston Biochem.
Expression and Purification of Proteins—All proteins were
expressed in Escherichia coli BL21(DE3) (Stratagene). His-
tagged proteins were purified via nickel-nitrilotriacetic acid
agarose (BD Biosciences) and glutathione S-transferase-
tagged proteins were purified using glutathione-Sepharose
(Amersham Biosciences). For untagged proteins, the puri-
fied proteins were subject to cleavage by thrombin (Nova-
gen). Proteins were dialyzed against Dulbecco’s phosphate-
buffered saline (pH 7.4).
In Vitro Reconstitution Assay—In
vitro ubiquitination assays were
performed in the presence of 0.1M
purified rabbit E1 (BioMol), 2 M
UbcH5a, 3 M CHIP, 50 M ubiq-
uitin (Sigma), 1 mM dithiothreitol
(DTT), 2mMMgCl2, and 4mMATP.
Reactions were carried out at 37 °C,
and samples were analyzed by SDS-
PAGE and immunoblotting using
appropriate antibodies.
RESULTS
Variations on Ubiquitin Conju-
gation Within a Single Reaction
System—A typical ubiquitination
reaction involves E1, E2, E3, and
substrates, with the products of
ubiquitin conjugation varying from
free ubiquitin chains, ubiquitin con-
jugated substrates, and autoubiq-
uitination products of E2 and E3 (1).
It is thus important to differentiate the substrate ubiquitination
from the other ubiquitin conjugates to fully analyze the func-
tionality of E3. E3 autoubiquitination has been treated as a hall-
mark activity for single subunit E3s (2). How this process is
coordinatedwith substrate ubiquitination remains unexplored.
To evaluate CHIP-mediated ubiquitin conjugation, we per-
formed a reconstituted in vitro ubiquitination assay using
UbcH5 as E2 and Hsp70 as the substrate of CHIP. Consistent
with our previous report (3), we observed nearly complete
polyubiquitination of Hsp70 in the presence of wild-type CHIP
(Fig. 1A, top panel). Notably, CHIP autoubiquitination was
restricted predominantly to monoubiquitination under these
circumstances (Fig. 1A,middle panel). This was not due to the
competition with Hsp70, as we observed a similar ubiquitina-
tion pattern with CHIP(K30A), a TPR mutant that does not
bind chaperones (Fig. 1A). In fact, the pattern of CHIP autou-
biquitination was unchanged in the absence or presence of
Hsp70 (supplemental Fig. S1).
Unexpectedly, UbcH5a underwent autoubiquitination in a
substrate-independent, E3-dependentmanner (Fig. 1A, bottom
panel). To separate isopeptide conjugates (UbcH5a-Ub) from
UbcH5a-Ub thioesters, we treated samples with DTT and
found that the DTT-sensitive thioesters migrate faster on SDS-
PAGE (17) (supplemental Fig. S2). By using a low concentration
of DTT, we were able to detect both UbcH5a-Ub and
UbcH5a-Ub thioester species on the same gel. Unlike some E2s
that are capable of assembling ubiquitin chains without E3 (1,
18), UbcH5a requires the presence of E3 to mediate ubiquitin
transfer. A U-box mutant of CHIP, H260Q, failed to generate
any ubiquitin conjugates, resulting in accumulation of
UbcH5a-Ub thioesters (Fig. 1A, bottom panel). Therefore, the
ratioofUbcH5a-UbandUbcH5a-Ub thioester species canbeused
as an indicator of the relative efficiency of ubiquitin transfer.
E2 autoubiquitination could be due to an intramolecular
transfer of ubiquitin from its own thioester bond, or to an inter-
molecular transfer. To distinguish these possibilities, we mixed
FIGURE 1. Ubiquitin transfer in a CHIP-mediated reaction system. A, in vitro ubiquitination of Hsp70 in the
presence of wild-type (WT) CHIP, CHIP(K30A), or CHIP(H260Q). At the indicated times, reaction aliquots were
removed and subjected to immunoblotting analysis with indicated antibodies. For UbcH5a detection, reaction
aliquots were treated with 1 mM DTT before immunoblot analysis. B, wild-type UbcH5a (nontagged) was mixed
with UbcH5a(C86A) (His6-tagged) in the presence () or absence () of CHIP. At the indicated times, reaction
aliquots were removed and treated with 1 mM DTT before immunoblot analysis. The above results are repre-
sentatives of at least three experiments. UbcH5Ub, UbcH5-Ub thioester.
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nontagged wild-type UbcH5a andHis6-taggedUbcH5a(C85A),
an active site mutant that cannot load ubiquitin via the thio-
ester bond. In the absence of CHIP, no ubiquitin transfer
occurred, confirming that ubiquitin transfer by UbcH5a is E3-
dependent (Fig. 1B). In the presence of CHIP, both wild-type
UbcH5a and the C85A mutant were ubiquitinated (Fig. 1B).
These results are consistent with an intermolecular transfer
from one activated E2-Ub thioester to another molecule of
UbcH5a, which do not need to be in the form of an E2-Ub
thioester. Therefore, the E3 not only recruits an E2-Ub thio-
ester but also plays a critical role in the activation of E2.
U-box Binding Is Required for Catalytic Activity of UbcH5—
The variations of ubiquitin conjugates in CHIP-mediated reac-
tions share one important feature. The formation of ubiquitin
isopeptide conjugates requires the presence of a functional
U-box. In the presence of CHIP(H260Q), a U-box mutant that
abolishes E2 binding, we did not detect any ubiquitin conju-
gates (Fig. 1A). Thus, the labile thioesters of UbcH5a-Ub do not
automatically lead to ubiquitin transfer. Further supporting
this notion, we failed to observe any ubiquitin transfer from
UbcH5-Ub toC85Amutant in the absence of CHIP (Fig. 1B). In
contrast, CHIP(K30A), a TPR domain mutant that abolishes
chaperone binding, maintains the capacity to mediate the for-
mation of ubiquitin isopeptide conjugates of UbcH5 (Fig. 1A).
Our results are in line with the recent report that the RING E3
triggers subtle conformation changes in the bound E2, stimu-
lating ubiquitin release from the E2 cysteine and transfer to the
substrate (4).
The E2 is at the center of a cascade of ubiquitin transfer,
linking activation of the ubiquitin by E1 to its eventual
E3-catalyzed attachment to substrates (5). In the CHIP-medi-
ated ubiquitination reaction, we considered UbcH5 autoubiq-
uitination as the by-product of molecular collision, similar to
Cdc34 in a SCF-mediated ubiquiti-
nation reaction (6). Because the cat-
alytic activity of UbcH5-Ub strictly
requires functional binding with the
U-box domain, the formation of
ubiquitin isopeptide conjugates of
UbcH5 provides an independent
assessment of E3 ligase activity.
This is especially useful to evaluate
the ligase activity of E3 mutants
with altered or no substrate bind-
ing, because no direct measure-
ment of the thioester bond reac-
tivity in E2-Ub is currently
available. Therefore, the nonproc-
essive UbcH5 autoubiquitination
is a substrate-independent index
of E3 ligase activity.
U-boxBinding IsNot Sufficient for
the Catalytic Activity of UbcH5—
Based on the requisite role of U-
box binding in triggering the cata-
lytic activity of UbcH5, we asked
whether the U-box alone is suffi-
cient to trigger ubiquitin transfer
from E2. In contrast to full-length CHIP, the presence of the
U-box domain alone did not lead to any conversion from
UbcH5a-Ub thioesters to the UbcH5a-Ub species (Fig. 2A).
Because E2 autoubiquitination is substrate-independent, we
asked whether the substrate-binding domain TPR is dispensa-
ble for E2 activation. However, deletion of the TPR domain
completely abolished the ubiquitin transfer from E2 (Fig. 2B).
Interestingly, removal of the helical linker region between the
TPR and U-box also significantly reduced the ligase activity of
CHIP (Fig. 2B). These results indicated that regions of the E3
other than theU-box alone play critical roles inmediating ubiq-
uitin transfer from the bound E2.
Dynamic Asymmetry of CHIP Homodimer—For many single
subunit RING or U-box E3s, there is accumulating evidence
indicating that oligomerization is required for function (21–
23). CHIP forms a homodimer, and the helical linker that con-
nects the TPR andU-box domains is required for dimer assem-
bly (24). A striking feature of the available atomic structure of
full-length CHIP homodimer is a radical asymmetry that arises
because the helical linker adopts two different conformations
(25). The asymmetric arrangement of TPR domains leaves only
one U-box of a dimer accessible to the E2 (Ref. 25 and Fig. 3).
Because neither the TPR domain nor the helical linker appears
to make direct contact with the bound E2 (25), we speculated
that a concerted and cooperativemechanismunderlies the acti-
vation of E2 by CHIP homodimer. We propose a dynamic
asymmetry model in which a CHIP homodimer is capable of
converting between symmetric and asymmetric conformations
without violating structural constraints.We animated the puta-
tive conformational transition of the CHIP homodimer using
the three-dimensional morphing software Blender (see supple-
mental Movie S1). Importantly, the modeled conformational
switch involving the two helical linkers does not disturb their
FIGURE 2. Regions of CHIP other than the U-box contribute to the catalytic activity of UbcH5a. A, in vitro
ubiquitination in the presence of full-length CHIP or U-box (U) alone. At the indicated times, reaction aliquots
were removed and immunoblotted with indicated antibodies. B, in vitro ubiquitination by deletion mutants of
CHIP, TPR, and Linker. At the indicated times, reaction aliquots were removed and immunoblotted with
indicated antibodies. The above results are representatives of at least three experiments. UbcH5Ub,
UbcH5-Ub thioester.
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dimerization interface (Fig. 3). Interestingly, the model passes
through a symmetric conformation in the middle of the transi-
tion that is strikingly similar to the symmetric structure of
CHIP lacking the TPR domain (Fig. 3, middle panel, and Ref.
26). The conformation at the end
point of the transition is identical to
the starting point but rotated 180°,
consistent with the observation
that only one conformation for the
full-length CHIP was found in the
x-ray crystal structure (25). An
immediate consequence of this
dynamic asymmetry is that the E2
binding site of each U-box cycles
between “on” and “off” due to the
recurring unmasking/masking by
the TPR domain. This molecular
switch would provide an alternating
access mechanism for TPR-at-
tached substrates to approach the
U-box-bound E2, followed by refill-
ing with subsequent E2 molecules.
Rebuilding a Functional Ubiq-
uitin Ligase—The dynamic asym-
metry model of the CHIP
homodimer predicts that the TPR
domain plays dual roles in ubiq-
uitination: recruiting substrates
and regulating E2 binding and
activation. As the substrate-bind-
ing-defective CHIP mutant K30A
retains its ability to activate E2
(Fig. 1A), the two putative roles of
the TPR domain appear to be
uncoupled. We therefore asked
whether the TPR domain could be
replaced by other domains with-
out affecting E2 activation. To this
end, we replaced the TPR domain
with FKBP. Remarkably, this chi-
meric protein FKBP(LU) retained
the same capacity as wild-type
CHIP to activate E2 (Fig. 4A). In
addition, we observed similar
results with a different domain
swap using FRB.
FKBP and FRB domains dimerize
with high affinity in the presence
of rapamycin (27). This property
allowed us to test whether the ligase
activity of the chimeric E3 can be
redirected toward new substrates.
We constructed FRB-fused GFP,
which can be recruited to FKBP(LU)
by rapamycin (supplemental Fig.
S3). Remarkably, addition of rapa-
mycin induced efficient ubiqui-
tin conjugation on FRB(GFP) (Fig.
3A). Reciprocal experiments that swapped FKBP and FRB
domains showed similar patterns of ubiquitin conjugation.
Notably, the chimeric proteins faithfully recapitulate the E3
properties of the full-length CHIP. For example, the autoubiq-
FIGURE 3. Computational modeling of the dynamic asymmetry of CHIP homodimer. The top panels show
crystal structures of the CHIP homodimer exhibiting asymmetric (A and C) and symmetric (B) conformations,
adopted from Refs. 25 and 26. Schematics were generated using PyMOL software. The bottom panels show
three-dimensional views of CHIP simulated using Blender 3D software based on matching locations of differ-
ent domains. Both the asymmetric (D and F) and symmetric (E) conformations are illustrated during the cycle of
conformational change. The TPR domain is shown as a blue cube with a dent as the chaperone-binding site. The
U-box is shown as an orange ball with a flat surface as the E2 binding site. The helical linker is shown as a green
bar. The flexible region in the helical linker is shown in gray in top panels.
FIGURE 4. Engineering ubiquitin ligases. A, the TPR domain of CHIP was replaced with FKBP or FRB domains,
generating recombinant ubiquitin ligases FKBP(LU) and FRB(LU). Using a rapamycin-mediated dimerization
approach, GFP proteins fused to FKBP or FRB were used as substrates. In vitro ubiquitination was performed in
the absence () or presence () of 1 M rapamycin (Rap). At the indicated times, reaction aliquots were
removed and immunoblotted with indicated antibodies. B, a schematic representation of different U-box
fusion proteins is shown. The CHIP U-box domain was fused to the carboxyl terminus of either FKBP or FRB in
the absence or presence of the helical linker. Fusion proteins containing the helical linker (i.e. FKBP(LU) and
FRB(LU)) form tight homodimers inherently. For fusion proteins without a helical linker (such as FKBP(U) and
FRB(U)), dimerization was induced using rapamycin. The functionality of chimeric U-box fusion proteins was
evaluated by either UbcH5a autoubiquitination or GFP substrates ubiquitin conjugation. , does not activate
UbcH5a-Ub; , activates UbcH5a-Ub; Ø, not done; HA, hemagglutinin. UbcH5Ub, UbcH5-Ub thioester.
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uitination of FKBP(LU) and FRB(LU) was independent of the
ubiquitination of GFP substrates (Fig. 4A).
An Engineered Ubiquitin Ligase Mimics the CHIP Homo-
dimer—The successful redesign of a ubiquitin ligase allowed us
to further substantiate the finding that structural flexibility is
required for CHIP-mediated ubiquitination. Consistent with
the results using the deletion mutant of CHIP lacking the heli-
cal domain, which eradicates CHIP structural flexibility, the
corresponding deletion mutation completely abolished the
ligase activity of recombinant E3 (FKBP-U and FRB-U) (Fig. 4B
and supplemental Fig. S4). For these experiments, we used the
FKBP-FRB dimerization approach, positioning the GFP pro-
teins bearing FRB domain (FRB-GFP) in the vicinity of recom-
binant ligase FKBP-U by adding rapamycin. No ubiquitin con-
jugation on FRB-GFP was detected (Fig. 4B and supplemental
Fig. S4). Using a similar approach, we further tested the func-
tionality of an artificial U-box dimer FKBP(U)/FRB(U) and
again found no evidence of E2 activation. To mimic the asym-
metry of the CHIP dimer that exhibits half-of-sites E2-binding
activity but without structural flexibility, we prepared a U-box
heterodimer by dimerizing a wild-type U-box and H260Q
mutant within the FKBP/FRB system. Once again, neither
FKBP(U)/FRB(HQ) nor FKBP(HQ)/FRB(U) triggered ubiq-
uitin transfer (Fig. 3B and supplemental Fig. S4). Taken
together, these results indicate that the full functionality of the
U-box in the context of full-length of CHIP cannot be repli-
cated in the form of U-box monomer, U-box dimer, or half-of-
sites heterodimer. Instead, it relies on the presence of both the
helical linker and the TPR domain, and the function of the TPR
domain canbe substituted by similarly positioned but unrelated
structures.
Flexible Orientation Accommodates Substrate Plasticity—
Several lines of evidence suggest that transient E2/E3 interactions
are required for repeated ubiquitin conjugation to attached sub-
strates. For example, themutually exclusivebindingofE1s andE3s
to E2s necessitates a recycling of E2s for addition of successive
ubiquitins to substrates (28). Dynamic E2/E3 interactions also
provide amechanism for E3 enzymes to accomplish a challeng-
ing task: targeting a substrate of continuously increasing size
(due to the growing ubiquitin chain)
and of different character, particu-
larly at the initial stages. The
dynamic model of CHIP we pro-
pose here coordinates substrate
approach, E2 activation, and sub-
sequent reloading. The intrinsic
structural flexibility of CHIP
enables E2 molecules to target
acceptor lysines on multiple sub-
strates with varied distances. To rig-
orously test the structural flexibility
of CHIP in ubiquitin transfer, we
constructed a fusion protein com-
prised of tandem GFPs with FRB at
the NH2 terminus to permit its
recruitment to the recombinant
ligase FKBP-LU (Fig. 5A). To differ-
entiate the ubiquitination of GFP1
from that of GFP2, we inserted a tobacco etch virus (TEV)
cleavage site between GFP1 and GFP2. After FKBP(LU)-medi-
ated ubiquitination in the presence of rapamycin, the reaction
products were treated with the AcTEV enzyme. The separated
GFP proteins were resolved on SDS-PAGE followed by immu-
noblotting using antibodies recognizing distinct epitope tags
located at GFP1 or GFP2 respectively. Remarkably, both GFP
proteins were ubiquitinated by the recombinant ubiquitin
ligase (Fig. 5B). GFP forms a cylindrical structure that has a
diameter of 30 Å and a length of 40 Å. Thus, even a distance of
about 100 Å (for tandem GFPs plus FRB) does not prevent the
substrate from accepting ubiquitin. Our results demonstrate a
striking flexibility within the CHIP dimer that facilitates ubiq-
uitin transfer and provides a mechanism to accommodate sub-
strates of diverse size and structure for ubiquitination.
DISCUSSION
Although multiple E2 and E3 enzyme structures have been
determined, including several E2-E3 complexes, it is becoming
increasingly apparent that static structural snapshots are not
sufficient to explain E3 catalysis (4). The prevailing view of the
function of RING finger (or U-box) E3s is that they provide a
scaffold that brings ubiquitin-charged E2 and substrate into
close proximity. However the hypothesis of “catalysis by prox-
imity” is not readily aligned with ubiquitination of substrates of
varied sizes. In addition, it remains unanswered how ubiquitin
shuttles from E2 to substrates. Our results reveal structural
flexibility of the E3 CHIP is required for the activation of a
bound E2 and the subsequent ubiquitin transfer. There is grow-
ing evidence that structural flexibility is an intrinsic property of
E3s. Conformational flexibility has been described in a HECT
E3WWP1/AIP5 (29) and, via cryo-electron microscopy, in the
multi-subunit RING E3 APC/C (30), although a causal link of
flexibility to E3 activity has until now been elusive. Analogous
to the ribosome,where structural flexibility is required for elon-
gation factor delivery and GTPase activation in the synthesis of
polypeptide (31), it may be that E3 cycling through different
conformational states is a common feature when ubiquitin is
assembled on a substrate molecule in a progressive manner.
FIGURE 5. Spatial flexibility of ubiquitin transfer allows ubiquitination of distant substrates. A, a sche-
matic diagram depicting the double GFP fusion protein bearing FRB. A Tev cleavage site was introduced
between GFP proteins to separate them after ubiquitination (Ub). B, in vitro ubiquitination of the double GFP
fusion protein by FKBP-LU in the presence of 1 M rapamycin. Reaction products were treated with AcTEV
enzyme and immunoblotted with indicated antibodies. For simplicity and clarity, only the linear ubiquitin
chain was illustrated, although we do not exclude the possibility of multiple ubiquitin chains or monoubiquiti-
nation. The above results are representatives of at least three experiments. , presence of indicated molecule;
, absence of indicated molecule.
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In addition to conformational flexibility, ligase asymmetry
is also a common theme. In the BRCA1/BARD1 het-
erodimer, only the RING domain in BRCA1 is responsible
for recruiting E2 (21). MDM2, the E3 designated for p53
ubiquitination, has a close partner, MDMX, whose RING
domain is not functional in E2 binding (22). Intriguingly, the
central acidic domain of MDM2 plays a critical role in p53
ubiquitination (32, 33). The observation that the RING
domains of MDM2 and MDMX are swappable only in the
presence of the acidic domain not only suggests asymmetric
features similar to those described here for CHIP but also
indicates the importance of structural flexibility.
The successful engineering of ubiquitin ligases implies a novel
approach to achieving specific protein knock-out. Researchers
have explored the possibility of modifying the ubiquitin pathway
to accelerate degradation of specific cellular proteins (34).
However, the approaches based on the substrate-binding pro-
tein F-box require endogenous Skp1-Cullin1-F-box-protein
core machinery to achieve ubiquitination. High levels of the
F-box chimera may squelch the core Skp1-Cullin1-F-box-pro-
tein and thus cripple the degradation of both the intended and
native substrates. Here, we demonstrate activity for an engi-
neered single-chain ubiquitin ligase, which is cell friendly
because it does not rely on other subunits for its functionality.
Moreover, we showed the novel E3 ligase can be readily engi-
neered into a small molecule-inducible version. This strategy
suggests a powerful and versatile tool to control protein ubiq-
uitination and degradation.
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